The European Commission published today a new call for “Medical technologies, Digital tools and Artificial Intelligence (AI) analytics to improve surveillance and care at high Technology Readiness Levels (TRL).” The call supports solutions that are close-to-market or for further developing and maturing innovative solutions in one of the COVID-19 areas.
The call is for Innovation Actions of one of the following two categories to:
- Support solutions that are close-to-market (TRL 7) in one of the COVID-19 areas mentioned below and that have already received, or are about to receive, the CE marking to proceed to large scale testing, piloting and deployment operations in critical healthcare areas (or wherever else is relevant) (type 1);
- Support market innovation (from lab-to-fab) for further developing and maturing innovative solutions that have already been validated in lab environments (TRL 6-7 or higher) with the aim to help accelerate developments and achieve conformity assessment (CE marking) (type 2).
This topic addresses consortia consisting of innovative technology providers, including SMEs, and/or organisations that can offer the range of activities required to address the objectives of the topic; the latter could for example be based on Digital Innovation Hubs, digital health accelerators and knowledge hubs, Centres offering Pilot Lines or similar technology, business and/or knowledge transfer organisations.
Expected EU contribution per proposal between EUR 2 and 5 million. For proposals with financial support to third parties (FSTP), up to EUR 10 million may be requested. Total budget for this call EUR 56 million.
The call is single stage and closes on 11th June 2020.
For more information, click here.
